Australia markets closed

Stemcell United Limited (SCU.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.01400.0000 (0.00%)
At close: 4:10PM AEST

Stemcell United Limited

126 Phillip Street
Level 5
Sydney, NSW 2000
Australia
61 2 8072 1400
http://www.scu.com.sg

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Huan Qing GuCEO, MD & Director239.55kN/AN/A
Mr. Chow-Yee KohCFO & Director90kN/A1976
Ms. Elizabeth SpoonerCompany Sec.N/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Stemcell United Limited, together with its subsidiaries, engages in the sourcing, producing, marketing, and selling of traditional medicines in Australia, Singapore, Greater China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company has a collaboration agreement with Temasek Polytechnic of Singapore to conduct joint research on the application of plant stem cell technology to the cultivation and commercial farming of seagrapes in Singapore; collaboration with Yunnan Hongyi Agriculture Development Co Ltd; and collaboration agreement with the University of Science, Malaysia to study the cultivation of sea grapes through the use of land-based and urban farming techniques. The company was formerly known as On Q Group Limited and changed its name to Stemcell United Limited in September 2015. Stemcell United Limited was incorporated in 1984 and is headquartered in Sydney, Australia.

Corporate governance

Stemcell United Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.